Global fluorescein angiography market to grow considerably by 2030

(Image Credit: AdobeStock/Thapana_Studio)

Imaging is a powerful tool for ophthalmologists as they diagnosis and treat patients with vision threatening conditions. Fluorescein angiography, fluorescent angiography, or fundus fluorescein angiography is one such tool, which uses a fluorescent dye and a specialized camera to examine the retina and choroid's blood flow.

The global market for fluorescein angiography is growing due to increasing prevalence of eye diseases, desire for early diagnosis, and government efforts to increase public awareness and reduce the number of those affected by blindness.

According to Straits Research, "The global fluorescein angiography market size was valued at USD 498.8 million in 2021 and is projected to reach USD 785.15 million by 2030, registering a CAGR of 5.17% from 2022 to 2030." The company’s research suggests that the market for fluorescein angiography is projected to be driven by the rising prevalence of eye-related ailments and the rising elderly population. Macular degeneration is a leading cause of the age-related eye condition that leads in the loss of central and crisp vision.

It should also be noted that adverse effects of the procedures dye include nausea, vomiting, and hives. Some individuals may also suffer dry mouth, a metallic taste in the tongue, an increase in salivation (saliva overproduction), sneezing, or a rapid heartbeat. Research suggests these effects may slow the expansion of this procedures market.

Regional analysis of the global fluorescein angiography market

The market is split by region into North America, Europe, Asia-Pacific, and LAMEA.

In 2019, North America dominated the market for fluorescein angiography with a 48.8 percent share. This company reports that this is due to the high number of diabetic retinopathy patients and high volume of procedures. The number of Americans suffering from diabetic retinopathy is projected to increase from 7.7 million in 2010 to 14.6 million in 2050, according to the National Eye Institute (NIH). Therefore, fundus cameras are utilized to identify diabetic retinopathy at an early stage.

These fundus cameras are used to identify a variety of retinal disorders. In the introduction, advanced features in cameras such as hybrid cameras, digital devices, and portability, a rapidly growing geriatric population, and a high prevalence of chronic diseases such as diabetes are cited as factors expected to boost the fluorescein angiography market over the forecast period.

Reference:

1. Global fluorescein angiography market Size is Estimated to Reach USD 785.15 million by 2030, Growing at a CAGR of 5.17%: Straits Research. Straits Research. December 11, 2023. Accessed December 21, 2023. https://www.globenewswire.com/news-release/2023/12/11/2794005/0/en/Global-fluorescein-angiography-market-Size-is-Estimated-to-Reach-USD-785-15-million-by-2030-Growing-at-a-CAGR-of-5-17-Straits-Research.html

2. Fluorescein Angiography Market Size, Share & Trends Analysis Report Product Outlook (Devices, Disposables, Dye, Film, Accessories), Technology Outlook (Digital, Analog, Others), Application Outlook (Macular edema, Macular degeneration, Macular pucker, Ocular melanoma, Diabetic retinopathy, Others) and By Region(North America, Europe, APAC, Middle East and Africa, LATAM) Forecasts, 2020-2030. https://straitsresearch.com/report/fluorescein-angiography-market